|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the ELN 6-K filed Mar 30, 2009. Capital
Expenditures
We believe that our current and planned manufacturing, research,
product development and corporate facilities will adequately
meet our current and projected needs. In June and December 2007,
we entered into lease agreements for two additional buildings in
South San Francisco, which are currently under
construction. The lease term for the first building commenced in
March 2009, and the lease for the second building is expected to
commence in the first quarter of 2010. The buildings will be
utilised for our R&D, sales and administrative functions.
We may invest a significant amount of cash and resources into
building a biologics manufacturing facility for bapineuzumab. We
will use our resources to make capital expenditures as necessary
from time to time and also to make investments in the purchase
or licensing of products and technologies and in marketing and
other alliances with third parties to support our long-term
strategic objectives.
This excerpt taken from the ELN 6-K filed Mar 31, 2008. Capital
Expenditures
We believe that our current and planned manufacturing, research,
product development and corporate facilities will adequately
meet our current and projected needs. In June and December 2007,
we entered into lease agreements for two additional buildings in
South San Francisco, which are currently under
construction. The lease term for the first building is expected
to commence in the first quarter of 2009 and the second in the
first quarter of 2010. The buildings will be utilised for our
R&D, sales and administrative functions. We may invest a
significant amount of cash and resources into building a
biologics manufacturing facility for AAB-001. We will use our
resources to make capital expenditures as necessary from time to
time and also to make investments in the purchase or licensing
of products and technologies and in marketing and other
alliances with third parties to support our long term strategic
objectives.
This excerpt taken from the ELN 6-K filed Mar 30, 2007. Capital
Expenditures
We believe that our current and planned manufacturing, research,
product development and corporate facilities will adequately
meet our current and projected needs. We are reviewing the
availability of additional space for our South
San Francisco facility. We will use our resources to make
capital expenditures as necessary from time to time and also to
make investments in the purchase or licensing of products and
technologies and in marketing and other alliances with third
parties to support our long term strategic objectives.
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for ELN: |
| |||||||
